JAN 2015
Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Bolger G, Helson L, Wolzt M. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharmacol Ther. 2015 Jan;53(1):54-65.
FEB 2014
Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FWA, Gurbel PA, Pirker-Kees A., Siller-Matula J. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke. 2014 Feb;45(2):492-503.
APR 2014
Aschauer S, Gouya G, Klickovic U, Storka A, Weisshaar S, Vollbracht C, Krick B, Weiss G, Wolzt M. Effect of systemic high dose vitamin C therapy on forearm blood flow reactivity during endotoxemia in healthy human subjects. Vascul Pharmacol. 2014 Apr;61(1):25-9.
APR 2014
Told R, Palkovits S, Schmidl D, Boltz A, Gouya G, Wolzt M, Napora KJ, Werkmeister R, Popa-Cherecheanu A, Garhfer G, Schmetterer L. Retinal hemodynamic effects of antioxidant supplementation in an endotoxin-induced model of oxidative stress in humans. Invest Ophthalmol Vis Sci. 2014 Apr 7;55(4):2220-7.
NOV 2014
Gouya G, Voithofer P, Neuhold S, Storka A, Vila G, Pacher R, Wolzt M, Huelsmann M. Association of Nutritional Risk Index with Metabolic Biomarkers, Appetite-Regulatory Hormones, and Inflammatory Biomarkers and Outcome in Patients with Chronic Heart Failure. IJCP 2014 Nov; 68(11):1293-300.
DEC 2014
Told R, Schmidl D, Palkovits S, Boltz A, Gouya G, Wolzt M, WitkowskaKJ, Popa-Cherecheanu A, Werkmeister RM, Garhfer G, Schmetterer L. Antioxidative capacity of a dietary supplement on retinal hemodynamic function in a human lipopolysaccharide (LPS) model. Invest Ophthalmol Vis Sci. 2014 Dec 18;56(1):403-11.
2014
Klickovic U, Doberer D, Gouya G, Aschauer S, Weisshaar S, Storka A, Bilban M, Wolzt M. Human Pharmacokinetics of High Dose Oral Curcumin and Its Effect on Heme Oxygenase-1 (Ho-1 Expression) in Healthy Male Subjects. Biomed Res Int. 2014;2014:458592.
JUL 2013
Weisshaar S, Gouya G, Nguyen D, Kapiotis S, Wolzt M. TheLPS-induced increase in circulating microparticles is not affected by vitamin C in humans. Eur J Clin Invest. 2013 Jul;43(7):708-15.
JUL 2013
Weisshaar S, Gouya G, Nguyen D, Kapiotis S, Wolzt M. TheLPS-induced increase in circulating microparticles is not affected by vitamin C in humans. Eur J Clin Invest. 2013 Jul;43(7):708-15.
AUG 2013
Wolzt M, Gouya G, Kapiotis S, BeckaM, Mueck W, Kubitza D. Open-label, randomized study of the effect of rivaroxaban with or without acetylsalicylic acid on thrombus formation in a perfusion chamber. Thromb Res. 2013 Aug;132(2):240-7.
SEP 2013
Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Helson L, Wolzt M. Effect of liposomal curcumin on red blood cells in vitro. Anticancer Res. 2013 Sep;33(9):3629-34.
SEP 2013
Siller-Matula JM, Francesconi M, Dechant C, Jilma B, Maurer G, Delle-Karth G, Gouya G, Ruzicka K, Podczeck-Schweighofer A, Christ G. Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study. Int J Cardiol. 2013 Sep 1;167(5):2018-23.
NOV 2013
Gouya G., Siller-Matula J., Fritzer-Szekeres M., Neuhold S., Storka A., Neuhofer LM, Clodi M., Hlsmann M., Pacher R., Wolzt M. Association of Endostatin with Mortality in Patients with Chronic Heart Failure. Eur J Clin Invest. 2013 Nov 5.
APR 2012
Wolzt M, Eriksson UG, Gouya G, Leuchten N, Kapiotis S, Elg M, Schtzer KM, Zetterstrand S, Holmberg M, Whlander K. Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists. Thromb Res. 2012 Apr;129(4):e83-91.
MAY 2012
Schaller G, Dittrich P, Felizeter M, Gouya G, Leuchten N, Kapiotis S, Vcelar B, Vorauer-Uhl K, Wolzt M. Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase. Int J Clin Pharmacol Ther. 2012 May 22;Volume 50(June):413-417.
NOV 2012
Gouya G, Palkovits S, Kapiotis S, Madl C, Locker G, Stella A, Wolzt M, Heinz G. Comparative bioactivity of subcutaneous low molecular weight heparin in critically ill patients with normal renal function. Brit J Clin Pharm. 2012 Nov;74(5):806-14.
MAR 2011
Gouya G, Sturm G, Lamina C, Zitt E, Freisttter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, and Kronenberg F. The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort. PLoS One. 2011 Mar 7;6(3):e17803.
AUG 2011
Gouya G, Hammer A, Elhenicky M, Neuhold S, Wolzt M, Hlsmann M, Pacher R. Benefit of specialized clinics for the treatment of patients with heart failure. Eur J Intern Med. 2011 Aug;22(4):428-31.
FEB 2010
Heinisch BB, Francesconi M, Mittermayer F, Schaller G, Gouya G, Wolzt M, Pleiner J. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. Eur J Clin Invest. 2010 Feb;40(2):148-54.
JAN 2010
Neuhold S, Huelsmann M, Strunk G, Struck J, Adlbrecht C, Gouya G, Elhenicky M, Pacher R. Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy. Clin Chem. 2010 Jan;56(1):121-6.
JAN 2010
Schaller G, Kretschmer S, Gouya G, Haider DG, Mittermayer F, Riedl M, Wagner O, Pacini G, Wolzt M, Ludvik B. Alcohol Acutely Increases Vascular Reactivity together with Insulin Sensitivity in Type 2 Diabetic Men. Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):57-60.
AUG 2009
Siller-Matula JM, Gouya G, Wolzt M, Jilma B. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers. Thromb Haemost. 2009 Aug;102(2):397-403.
MAY 2009
Gouya G, Jilma B, Niel M, Eichelberger B, Wolzt M, Panzer S. Cross validation of aspirin effect ni healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial. Platelets. 2009 May;20(3):171-6.
2008
Gouya G, Reichardt B, Bidner A, Weissenfels R, Wolzt M. [Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients]. Wien Klin Wochenschr. 2008;120(3-4):89-95.
2007
Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol. 2007;22(3):145-9.
2007
Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol. 2007;22(3):145-9.
MAR 2007
Risch L, Saely CH, Neyer U, Hoefle G, Gouya G, Zerlauth M, Risch GM, Risch M, Drexel H. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care-an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates. Clin Chim Acta. 2007 Mar;378(1-2):71-7.
DEC 2006
Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L, Kapiotis S, Wolzt M. C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol. 2006 Dec; 146(3):533-9.
SEP 2006
Phringer P, Gouya G, Reichardt B, Wolzt M. Sex-specific antihypertensive drug therapy. Wien Med Wochenschr. 2006 Sep;156(17-18):498-500.
FEB 2007
Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G, Marte T, Aczel S, Drexel H. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta.2007 Feb;376(1-2):108-13.
NOV 2006
Risch L, Hoefle G, Saely C, Berchthold S, Weber M, Gouya G, Rein P, Langer P, Marte T, Aczel S, Drexel H. Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum. Clin Chim Acta. 2006 Nov;373(1-2):121-6.
JUL 2003
Hfle G, Holzmller H, Gouya G, Hergan K, Hubmann M, Langer P, Drexel H. Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone. Transpl Int. 2003 Jul;16(7):523-8.
OCT 2002
Plzl G, Gouya G, Hgel H, Frick M, Ulmer H, Pachinger O. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic]. Wien Klin Wochenschr. 2002 Oct 31;114(19-20):833-9.
MAR 1997
Schmetterer L, Krejcy K, Kastner J, Wolzt M, Gouya G, Findl O, Lexer F, Breiteneder H, Fercher AF, Eichler HG. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res. 1997 Mar;64(3):305-12.
DEC 1995
Schmetterer L, Wolzt M, Lexer F, Alschinger C, Gouya G, Zanaschka G, Fassolt A, Eichler HG, Fercher AF. The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men. Exp Eye Res. 1995 Dec;61(6):685-90.
OCT 1995
Wolzt M, Schmetterer L, Gouya G, Zanaschka G, EichlerHG. Is the ECG measure RSh a promising technique for detecting class I antiarrhythmic drug action in men J Cardiovasc Pharmacol. 1995 Oct;26(4):660-5.
Learn the most common CTIS submission mistakes in Part I and Part II documents. Submit your EU CTIS without delays.
Read More
Early-stage biotech companies often contact the EMA too late. Learn when and how to request an EMA Innovation Task Force (ITF) meeting, how it differs from Scientific Advice, and what...
Read More
Wien, 10.12.2024 – Text: Catarina Carrão Combination products Combination products are progressively integrating cutting edge, novel technologies that hold great promise for advancing patient care. Such innovative drug, biological product, device...
Read MoreWien, 18.11.2024 – Text: Catarina Carrão The General Framework for harmonised European Standards (hES) Under the MDR 2017/745 and IVDR 2017/746 regulations, harmonized European standards (hES) play an important role. The legislation only sets out...
Read MoreWien, 11.10.2024 – Text: Catarina Carrão In vitro diagnostic (IVD) devices: clinical performance studies Despite extended transition periods and multiple guidelines, IVDR remains difficult to interpret and bringing devices into compliance requires additional efforts. The...
Read MoreWien, 01.08.2024 – Text: Catarina Carrão In vitro diagnostic (IVD) medical devices In vitro diagnostic (IVD) devices play a critical role whether to help diagnose diseases or conditions, monitor health...
Read MoreWien, 09.07.2024 – Text: Catarina Carrão Medical technology start-ups: popular demand The need for innovative healthcare solutions is high, as such medical technology start-ups are increasingly popular. Whether developing new technologies, devices,...
Read MoreWien, 02.07.2024 – Text: Catarina Carrão Rare diseases in the EU In the European Union (EU), 27 to 36 million people live with one of the estimated 6,000 to 8,000...
Read MoreA report of the inaugural JAMA Summit Wien, 17.06.2024 – Text: Catarina Carrão The inaugural Journal of the American Medical Association (JAMA) Summit 1 was held last October and focused on clinical trials, the basis of evidence-based medicine. It was meant...
Read MoreNora holds degrees in law from Janus Pannonius University and in pharmacy from Semmelweis University, combining legal and scientific expertise. She is a certified Data Protection Officer with hands-on experience supporting GDPR compliance and contractual safeguards for biotech and pharma clients. With over 20 years in clinical research, she brings a pragmatic, risk-aware approach to data protection in global trials
